Filed December 28, 2020
`
`On behalf of Illumina, Inc.
`By: Kerry S. Taylor
`
`Nathanael R. Luman
`Michael L. Fuller
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Fax: (858) 707-4001
`Tel.: (858) 707-4000
`Email: BoxIllumina@knobbe.com
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`ILLUMINA, INC.
`Petitioner,
`
`v.
`
`TRUSTEES OF COLUMBIA UNIVERSITY
`IN THE CITY OF NEW YORK
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-01177
`Patent 10,435,742
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ILLUMINA UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`On behalf of Illumina, Inc.
`By: Kerry S. Taylor
`
`Nathanael R. Luman
`Michael L. Fuller
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Fax: (858) 707-4001
`Tel.: (858) 707-4000
`Email: BoxIllumina@knobbe.com
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________________________
`
`ILLUMINA, INC.
`Petitioner,
`
`v.
`
`TRUSTEES OF COLUMBIA UNIVERSITY
`IN THE CITY OF NEW YORK
`Patent Owner.
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2020-01177
`Patent 10,435,742
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`ILLUMINA UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`
`
`Pursuant to 37 C.F.R. § 42.63(e), Petitioner Illumina, Inc. (“Illumina”)
`
`hereby provides an updated list of its exhibits in this proceeding.
`
`Exhibit
`No.
`
`1001
`
`1002
`
`1003
`
`1004
`
`1013
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`1023
`
`1024
`
`EXHIBIT LIST
`
`Description
`
`U.S. Patent No. 10,407,458 (“Ju”) – (guanine with allyl proviso)
`
`U.S. Patent No. 10,407,459 (“Ju”) – (adenine with allyl proviso)
`
`U.S. Patent No. 10,457,984 (“Ju”) – (cytosine with allyl proviso)
`
`U.S. Patent No. 10,435,742 (“Ju”) – (thymine with allyl proviso)
`
`Exhibit numbers 1005-1012 not used.
`
`U.S. Patent No. 7,790,869 (“Ju”)
`
`U.S. Patent No. 7,713,698 (“Ju”)
`
`U.S. Patent No. 8,088,575 (“Ju”)
`
`U.S. Patent No. 9,718,852 (“Ju”) – (adenine)
`
`U.S. Patent No. 9,719,139 (“Ju”) – (thymine)
`
`U.S. Patent No. 9,708,358 (“Ju”) – (cytosine)
`
`U.S. Patent No. 9,725,480 (“Ju”) – (guanine)
`
`U.S. Patent No. 9,868,985 (“Ju”) – (method)
`
`2014-03-06 IPR2012-00007, Paper 140, Final Written Decision
`
`2014-03-06 IPR2012-00006, Paper 128, Final Written Decision
`
`2014-03-06 IPR2013-00011, Paper 130, Final Written Decision
`
`2019-06-21 IPR2018-00291, -00318, -00322, -00385, Final Written
`Decisions
`
`- 1 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`Exhibit numbers 1025-1027 not used.
`
`1028
`
`2019-09-09 IPR2018-00797, Final Written Decision
`
`1029
`
`2015-07-17 Federal Circuit Opinion Affirming IPR2012-00006,
`IPR2012-00007 and IPR2013-00011
`
`1030
`
`U.S. Patent No. 5,547,839 (“Dower”)
`
`1031 WO 91/06678 (“Tsien”)
`
`1032
`Exhibit number not used
`1033 Welch et al., “Syntheses of Nucleosides Designed for Combinatorial
`DNA Sequencing,” Chem. Eur. J., 5:951-960 (1999) (“Welch”)
`
`Exhibit numbers 1034-1036 not used.
`
`1037
`
`Alberts et al., “Molecular Biology of the Cell,” Third Edition, Garland
`Publishing Inc., New York (1994)
`
`1038
`
`Exhibit number not used
`
`1039
`
`1040
`
`1041
`
`1042
`
`1043
`
`Metzker et al., “Termination of DNA synthesis by novel 3’-modified-
`deoxyribonucleoside 5’-triphosphates,” Nucleic Acids Research,
`22:4259-67 (1994) (“Metzker”)
`
`Sanger et al., “DNA sequencing with chain-terminating inhibitors,”
`Proc. Nat’l Acad. Sci. USA, 74:5463-5467 (1977) (“Sanger”)
`
`Prober et al., “A System for Rapid DNA Sequencing with Fluorescent
`Chain-Terminating Dideoxynucleotides,” Science, 238:336-341 (1987)
`(“Prober”)
`
`U.S. Patent No. 5,302,509 (“Cheeseman”)
`
`U.S. Patent No. 5,763,594 (“Hiatt”)
`
`- 2 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`1044
`
`Description
`
`Pelletier et al., “Structures of Ternary Complexes of Rat DNA
`Polymerase β, a DNA Template-Primer, and ddCTP,” Science,
`264:1891-1903 (1994) (“Pelletier”)
`
`1045
`
`Exhibit number not used
`
`1046
`
`Rosenblum et al., “New dye-labeled terminators for improved DNA
`sequencing patterns,” Nucleic Acid Research, 25:4500-4504 (1997)
`(“Rosenblum”)
`
`1047
`
`Exhibit number not used
`
`1048
`
`1049
`
`1050
`
`Excerpts from 2019-01-14 Deposition Transcript of Dr. Menchen in
`IPR2018-00291, -00318, -00322, and -00797
`
`2018-05-04 IPR2018-00385, Paper 13, Patent Owner Preliminary
`Response
`
`Canard et al., “Catalytic editing properties of DNA polymerases,” Proc.
`Nat’l Acad. Sci. USA, 92:10859-10863 (1995) (“Canard”)
`
`1051
`
`Exhibit number not used
`
`1052
`
`1053
`
`1054
`
`1055
`
`Yu et al., “Cyanine dye dUTP analogs for enzymatic labeling of DNA
`probes,” Nucleic Acids Research, 22:3226-3232 (1994) (“Yu”)
`
`Livak et al., “Detection of single base differences using biotinylated
`nucleotides with very long linker arms,” Nucleic Acids Research,
`20:4831-4837 (1992) (“Livak”)
`
`Stryer, “Biochemistry,” Fourth Edition, W.H. Freeman and Co., New
`York (1995) (“Stryer”)
`
`Watson & Crick, “Genetical Implication of the Structure of
`Deoxyribonucleic Acid,” Nature, 171:964-967 (1953) (“Watson &
`Crick”)
`
`1056
`
`U.S. Patent No. 5,151,507 (“Hobbs”)
`
`- 3 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`1057
`
`Exhibit number not used
`
`1058
`
`Excerpts from Sept. 4-5, 2013 Deposition Transcript of Dr. George L.
`Trainor in IPR2012-00007
`
`1059
`
`Exhibit number not used
`
`1060
`
`1061
`
`1062
`
`1063
`
`Hovinen et al., “Synthesis of 3´-O-(ω-Aminoalkoxymethyl)thymidine
`5´-Triphosphates, Terminators of DNA Synthesis that Enable 3’-
`Labeling,” J. Chem. Soc. Perkin Trans. 1, 211-217 (1994) (“Hovinen”)
`
`Exhibit number not used
`
`Excerpt from Prosecution History of U.S. Patent No. 9,725,480
`
`Ireland et al., “Approach to the Total Synthesis of Chlorothricolide:
`Synthesis of (±)-19,20-Dihydro-24-O-methylchlorothricolide, Methyl
`Ester, Ethyl Carbonate,” J. Org. Chem. 51:635-648 (1986) (“Ireland”)
`
`1064
`
`Exhibit number not used
`
`1065
`
`1066
`
`1067
`
`1068
`
`1069
`
`1070
`
`1071
`
`Excerpt from Prosecution History of U.S. Patent No. 10,428,380 [U.S.
`Appl. No. 16/150,191] (2019-03-12 Pre-interview first office action)
`
`Ruparel et al., “Design and synthesis of a 3´-O-allyl photocleavable
`fluorescent nucleotide as a reversible terminator for DNA sequencing
`by synthesis,” PNAS, Vol. 102, No. 17, 5932-37 (2005) (“Ruparel”)
`
`Ju et al., “Four-color DNA sequencing by synthesis using cleavable
`fluorescent nucleotide reversible terminators,” PNAS, Vol. 103, No.
`52, 19635-40 (2006) (“Ju”)
`
`2015-02-11 IPR2013-00517, Paper 87, Final Written Decision
`
`2016-05-09 Federal Circuit Opinion Affirming IPR2013-00517
`
`U.S. Patent No. 5,449,767 (“Ward”)
`
`Exhibit number not used
`
`- 4 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`1072 WO 98/33939 (“Anazawa”)
`
`1073
`
`1074
`
`1075
`
`1076
`
`1077
`
`1078
`
`1079
`
`1080
`
`1081
`
`1082
`
`1083
`
`1084
`
`Anazawa (English Translation of WO 98/33939)
`
`Exhibit number not used
`
`PROTECTIVE GROUPS IN ORGANIC SYNTHESIS (Theodora W.
`Greene & Peter G.M. Wuts eds., 3rd ed. 1999) (excerpts) (“Greene &
`Wuts”)
`
`Boss et al., “Cleavage of Allyl Ethers with Pd/C,” Angew. Chem. Int.
`Ed. Engl., 15:558-559 (1976) (“Boss”)
`
`Qian et al., “Unexpected Enzymatic Fucosylation of the Hindered
`Tertiary Alcohol of 3-C-Methyl-N-Acetyllactosamine Produces a
`Novel Analogue of the LeX-Trisaccharide,” J. Am. Chem. Soc.,
`120:2184-2185 (1998) (“Qian”)
`
`Kamal et al., “A Mild and Rapid Regeneration of Alcohols from their
`Allylic Ethers by Chlorotrimethylsilane/Sodium Iodide,” Tetrahedron
`Letters, 40:371-372 (1999) (“Kamal”)
`
`2014-07-25 Final Written Decision in IPR2013-00128, Paper 92
`
`2014-10-28 Final Written Decision in IPR2013-00266, Paper 73
`
`2016-01-29 Federal Circuit Opinion Affirming IPR2013-00128 and
`IPR2013-00266
`
`IPR2017-02172, Paper 20 (P.T.A.B. 2018)
`
`IPR2017-02174, Paper 20 (P.T.A.B. 2018)
`
`Meng et al., “Design and Synthesis of a Photocleavable Fluorescent
`Nucleotide 3´-O-Allyl-dGTP-PC-Bodipy-FL-510 as a Reversible
`Terminator for DNA Sequencing by Synthesis,” J. Org. Chem. 71,
`3248-3252 (2006) (“Meng”)
`
`- 5 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`1085
`
`Bi et al., “Design and Synthesis of a Chemically Cleavable Fluorescent
`Nucleotide, 3´-O-Allyl-dGTP-allyl-Bodipy-FL-510, as a Reversible
`Terminator for DNA Sequencing by Synthesis,” J. Am. Chem. Soc.,
`128, 2542-2543 (2006) (“Bi”)
`1086 Meng thesis from Dr. Ju’s laboratory at Columbia University (2006)
`(“Meng Thesis”)
`
`1087
`
`Wu, et al., “3´-O-modified nucleotides as reversible terminators for
`pyrosequencing,” PNAS, Vol. 104, No. 42, 16462-16467 (2007)
`(“Wu”)
`
`1088
`
`Kim thesis from Dr. Ju’s laboratory at Columbia University (2008)
`(“Kim Thesis”)
`1089 Wu thesis from Dr. Ju’s laboratory at Columbia University (2008)
`(“Wu Thesis”)
`
`1090
`
`Zhang thesis from Dr. Ju’s laboratory at Columbia University (2008)
`(“Zhang Thesis”)
`
`1091
`
`1092
`
`1093
`
`1094
`
`Guo et al., “Four-color DNA sequencing with 3´-O-modified
`nucleotide reversible terminators and chemically cleavable fluorescent
`dideoxynucleotides,” PNAS, Vol. 105, No. 27, 9145-9150 (2008)
`(“Guo”)
`
`Guo thesis from Dr. Ju’s laboratory at Columbia University (2009)
`(“Guo Thesis”)
`
`Yu thesis from Dr. Ju’s laboratory at Columbia University (2010) (“Yu
`Thesis”)
`
`Qui thesis from Dr. Ju’s laboratory at Columbia University (2011)
`(“Qui Thesis”)
`
`1095
`
`Exhibit number not used
`
`1096
`
`Lipshutz et al., “Hydrolysis of Acetals and Ketals Using LiBF4,”
`Synthetic Communications, 12:4, 267-277 (1982)
`
`- 6 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`1097
`
`1098
`
`1099
`
`1100
`
`1104
`
`1105
`
`1106
`
`1107
`
`1108
`
`1109
`
`Curriculum Vitae of Floyd Romesberg, Ph.D.
`
`Exhibit number not used
`
`U.S. Patent No. 7,270,951 (“Stemple”)
`
`Kraevskii et al., Molecular Biology 21:25-29 (1987) (“Kraevskii”)
`
`Exhibit numbers 1101-1103 not used.
`
`Seitz et al., HYCRON, an Allylic Anchor for High-Efficiency Solid
`Phase Synthesis of Protected Peptides and Glycopeptides,” J. Org.
`Chem., 62:813-826 (1997) (“Seitz”)
`
`Greenberg et al., “Optimization and Mechanistic Analysis of
`Oligonucleotide Cleavage from Palladium-Labile Solid-Phase
`Synthesis Supports,” J. Org. Chem., 63:4062-4068 (1998)
`(“Greenberg”)
`
`Gullier et al., “Linkers and Cleavage Strategies in Solid-Phase Organic
`Synthesis and Combinatorial Chemistry,” Chem. Rev., 100:2091-2157
`(2000) (“Guillier Review 2000”)
`
`Fields, Methods in Molecular Biology, Volume 35, Peptide Synthesis
`Protocols, Chapter 2, Humana Press 1994 (“Fields”)
`
`Gigg et al., “The Allyl Ether as a Protecting Group in Carbohydrate
`Chemistry Part II”, J. Chem. Soc. (C), 1903-1911 (1968) (“Gigg”)
`
`IUPAC, Nomenclature of Organic Chemistry, Eds. Rigaudy et al.,
`International Union of Pure and Applied Chemistry, Organic Chemistry
`Division, Commission on Nomenclature of Organic Chemistry,
`Pergamon Press, 1979.
`
`1110
`
`CRC Handbook of Chemistry and Physics, eds. Weast et al., 72nd
`edition, CRC Press (1991)
`1111 McGraw-Hill Dictionary of Chemistry, ed. Parker, McGraw-Hill Book
`Co., 1984
`
`- 7 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`1112
`
`Description
`
`Vollhardt et al., “Organic Chemistry,” W.H. Freeman and Co., New
`York (2d ed. 1994) (“Vollhardt”)
`
`1113
`
`Solomons, “Organic Chemistry”, Fourth Edition, John Wiley & Sons
`(1988) (“Solomons”)
`1114 Morrison et al., “Organic Chemistry,” Third Edition, Allyn and Bacon,
`Inc. (1973)
`
`1115
`
`1116
`
`1117
`
`1118
`
`1119
`
`1120
`
`1121
`
`Dominguez et al., “DNA polymerase mu (Pol μ), homologous to TdT,
`could act as a DNA mutator in eukaryotic cells,” The EMBO Journal,
`19(7): 1731-1742 (2000) (“Dominguez”)
`
`Ito et al., “Compilation and alignment of DNA polymerase sequences,”
`Nucleic Acids Research, 19: 4045-4057 (1991) (“Ito”)
`
`Collins et al., “A rapid method for mRNA detection in single-cell
`Biopsies from preimplantation-stage bovine embryos,”
`Theriogenology, 43: 1227-1238 (1995) (“Collins”)
`
`Haber et al., “Diagnosis of Flame Chlorosis by Reverse Transcription–
`Polymerase Chain Reaction (RT-PCR),” Plant Disease, 79(6): 626-630
`(1995) (“Haber”)
`
`Sidorova et al., “A rapid RT-PCR based method for the detection of
`BCR-ABL translocation,” J. Clin Pathol: Mol Pathol 50: 266-268
`(1997) (“Sidorova”)
`
`Stromskaya et al., “Cell-specific effects of RAS oncogene and protein
`kinase C agonist TPA on P-glycoprotein function,” FEBS Letters, 368:
`373-376 (1995) (“Stromskaya”)
`
`Bechtereva et al., “DNA sequencing with thermostable Tet DNA
`polymerase from Thermus thermophilus,” Nucleic Acids Research, 17:
`10507 (1989) (“Bechtereva”)
`
`- 8 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`1122
`
`1123
`
`1131
`
`1132
`
`1133
`
`1134
`
`1135
`
`1136
`
`Description
`
`Asakura et al., “Cloning, Nucleotide Sequence, and Expression in
`Escherichia coli of DNA Polymerase Gene (polA) from Thermus
`thermophilus HB8,” Journal of Fermentation and Bioengineering,
`76(4): 265-269 (1993) (“Asakura”)
`
`Ikeda et al., “A Non-radioactive DNA Sequencing Method Using
`Biotinylated Dideoxynucleoside Triphosphates and ΔTth DNA
`Polymerase,” DNA Research, 2: 225-227 (1995) (“Ikeda”)
`
`Exhibit numbers 1124-1130 not used.
`
`Declaration of Dr. Floyd Romesberg, Ph.D.
`
`List of documents considered by Floyd Romesberg, Ph.D.
`
`Excerpt from Prosecution History of U.S. Patent No. 10,435,742
`(Declaration of Jingyue Ju and Accompanying Documents)
`
`Excerpt from Prosecution History of U.S. Patent No. 10,435,742
`(2019-02-15 Pre-interview First Office Action)
`
`Excerpt from Prosecution History of U.S. Patent No. 10,435,742
`(2019-02-26 Applicant Arguments/Remarks Made in an Amendment)
`
`Excerpt from Prosecution History of U.S. Patent No. 10,435,742
`(2019-05-13 Applicant Arguments/Remarks Made in an Amendment)
`
`1137 William R. Zimmerman Declaration in support of pro hac vice motion
`
`Exhibit numbers 1138-1145 not used.
`
`1146
`
`1147
`
`Stipulated Extension of Time #1, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 7, 19-cv-01681 (D. Del.) (Sept. 19, 2019)
`
`Stipulated Extension of Time #2, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 31, 19-cv-01681 (D. Del.) (Mar. 20, 2020)
`
`- 9 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`1148
`
`1149
`
`1150
`
`1151
`
`1152
`
`1153
`
`1154
`
`1155
`
`1156
`
`Stipulated Extension of Time #3, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 34, 19-cv-01681 (D. Del.) (Apr. 15, 2020)
`
`Stipulated Extension of Time #4, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 39, 19-cv-01681 (D. Del.) (May 20, 2020)
`
`Stipulated Extension of Time #5, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 45, 19-cv-01681 (D. Del.) (Jun. 25, 2020)
`
`Stipulated Extension of Time #6, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 50, 19-cv-01681 (D. Del.) (Jul. 14, 2020)
`
`Stipulated Extension of Time #7, The Trustees of Columbia University
`in the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 65, 19-cv-01681 (D. Del.) (Oct. 2, 2020)
`
`Docket, The Trustees of Columbia University in the City of New York
`and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.)
`(current as of Nov. 11, 2020)
`
`Scheduling Order, The Trustees of Columbia University in the City of
`New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I. 17, 19-cv-
`01681 (D. Del.) (Dec. 11, 2019)
`
`Standing Order Regarding Criminal and Civil Jury Selections; Jury
`Trials; And Transition to Phase 2, In re: Court Operations Under the
`Exigent Circumstances Created by COVID-19 (D. Del.) (Sept. 1, 2020)
`
`Claim Construction Order, The Trustees of Columbia University in the
`City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I. 60,
`19-cv-01681 (D. Del.) (Sept. 10, 2020)
`
`- 10 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`Description
`
`1157
`
`1158
`
`1159
`
`1160
`
`1161
`
`1162
`
`1163
`
`1164
`
`Joint Claim Construction Brief, The Trustees of Columbia University in
`the City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I.
`54, 19-cv-01681 (D. Del.) (Aug. 10, 2020)
`
`Joint Claim Construction Appendix, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 55, 19-cv-01681 (D. Del.) (Aug. 10, 2020)
`
`Columbia’s Motion for Reconsideration of the Court’s Claim
`Construction Order, The Trustees of Columbia University in the City of
`New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I. 63, 19-cv-
`01681 (D. Del.) (Sept. 16, 2020)
`
`Illumina’s Answer to Columbia’s Motion for Reconsideration of the
`Court’s Claim Construction Order, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 64, 19-cv-01681 (D. Del.) (Sept. 30, 2020)
`
`Transcript of Markman Hearing on Claim Construction, The Trustees
`of Columbia University in the City of New York and Qiagen Sciences,
`LLC v. Illumina, Inc., 19-cv-01681 (D. Del.) (Sept. 2, 2020)
`
`Columbia’s Claim Construction Presentation for Markman Hearing,
`The Trustees of Columbia University in the City of New York and
`Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.) (Sept. 2,
`2020)
`
`Illumina’s Claim Construction Presentation for Markman Hearing, The
`Trustees of Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.) (Sept. 2, 2020)
`
`Columbia’s Motion to Take Judicial Notice of Documents Filed in
`IPR2020-00988, The Trustees of Columbia University in the City of
`New York v. Illumina, Inc., D.I. 51, 19-2302 (Fed. Cir.) (Sept. 16,
`2020)
`
`- 11 -
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`Exhibit
`No.
`
`1165
`
`1166
`
`Description
`
`Illumina’s Opposition to Columbia’s Motion to Take Judicial Notice of
`Documents Filed in IPR2020-00988, The Trustees of Columbia
`University in the City of New York v. Illumina, Inc., D.I. 53, 19-2302
`(Fed. Cir.) (Sept. 25, 2020)
`
`Columbia’s Reply to Illumina’s Opposition to Columbia’s Motion to
`Take Judicial Notice of Documents Filed in IPR2020-00988, The
`Trustees of Columbia University in the City of New York v. Illumina,
`Inc., D.I. 54 19-2302 (Fed. Cir.) (Oct. 2, 2020)
`
`1167
`
`Exhibit number not used.
`
`Stipulation and Order amending the case schedule and cancelling the
`trial date, The Trustees of Columbia University in the City of New York
`and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681, D.I. 74
`(D. Del.) (Dec. 16, 2020)
`Exhibit submitted pursuant to emailed authorization of the PTAB on
`December 28, 2020.
`
`Respectfully submitted,
`
`By: /Kerry Taylor/
`Kerry Taylor (Reg. No. 43,947)
`Nathanael R. Luman (Reg. No. 63,160)
`Michael L. Fuller (Reg. No. 36,516)
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`Attorneys for Petitioner
`ILLUMINA, INC.
`
`
`
`- 12 -
`
`1168
`
`
`
`
`Dated: December 28, 2020
`
`
`
`
`
`Illumina v. Columbia
`IPR2020-01177– Patent 10,435,742
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that true and correct copies of the foregoing ILLUMINA
`
`UPDATED EXHIBIT LIST and EXHIBIT 1168 are being served on
`
`December 28, 2020, via email, pursuant to agreement of the parties, to counsel for
`
`the Trustees of Columbia University in the City of New York, at the email
`
`addresses below:
`
`John P. White
`jwhite@cooperdunham.com
`Gary J. Gershik
`ggershik@cooperdunham.com
`ColumbiaIPR@cooperdunham.com
`Cooper & Dunham, LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`
`
`John D. Murnane
`VENABLE LLP
`jmurnane@venable.com
`1290 Avenue of the Americas
`New York, NY 10104
`
`Justin J. Oliver
`VENABLE LLP
`joliver@venable.com
`600 Massachusetts Ave.
`Washington, D.C. 20001
`
`
`
`By: /Kerry Taylor/
`Kerry Taylor (Reg. No. 43,947)
`Nathanael R. Luman (Reg. No. 63,160)
`Michael L. Fuller (Reg. No. 36,516)
`William R. Zimmerman (pro hac vice)
`KNOBBE, MARTENS, OLSON & BEAR, LLP
`Attorneys for Petitioner
`ILLUMINA, INC.
`
`
`
`Dated: December 28, 2020
`
`34121783
`
`
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
